Open Access · CC BY 4.0
Correction to “Direct cellular targets and anticancer mechanisms of the natural product oridonin”
MedComm – Future Medicine · 2026-12 · 5 (4)
DOI: 10.1002/mef2.70095 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm – Future Medicine, online erschienen am 03.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Direct cellular targets and anticancer mechanisms of the natural product oridonin”. MedComm – Future Medicine, 5(4). https://doi.org/10.1002/mef2.70095
Vancouver
Correction to “Direct cellular targets and anticancer mechanisms of the natural product oridonin”. MedComm – Future Medicine. 2026;5(4). doi:10.1002/mef2.70095
BibTeX
@article{euvimed2026,
title = {Correction to “Direct cellular targets and anticancer mechanisms of the natural product oridonin”},
journal = {MedComm – Future Medicine},
year = {2026},
volume = {5},
number = {4},
doi = {10.1002/mef2.70095}
}
EUVIMED